How we work with the healthcare industry
MSIF has formed a mutually beneficial relationship with the corporate sector over many years
Last updated: 28th May 2026
Whilst always protecting its independence, MSIF has formed a mutually beneficial relationship with the corporate sector over many years. The development of MS treatments and other products has led to growing interest in the work of the MS International Federation by healthcare companies. As a result they have supported MSIF projects that have benefited people with MS around the world.
Although much attention has been focused on the pharmaceutical and biotech industries, there are other health sectors that may wish to support MSIF and its member MS societies. These include manufacturers and suppliers of medical devices and aids to daily living, dietary supplements, health management organisations, nursing/homecare agencies and insurers.
Healthcare companies are important stakeholders in the MS space and where we have shared goals we welcome their support of our work. We also recognise that not all of our goals are aligned so do not accept any interference or influence over any programme design or delivery. In support of this we also always try to secure multi-stakeholder funding for projects to reduce the risk of individual influence.
To acknowledge the unique role of healthcare companies in the MS space we have a detailed policy covering our engagement with them: ‘Healthcare Industry Policy 2026‘. This covers relationships involving financial arrangements, and non-financial relationships.
2024 healthcare industry support
The information below shows the exact amount we received from the healthcare industry in 2024 and the programmes they supported.
Bristol Myers Squibb £15,000
Improved Scientific Understanding
- Atlas of MS
Greater Access to Effective Healthcare, Information & Support
- Access to Diagnosis
- World MS Day
A Stronger Broader Global MS Movement
- Organisational Development and Movement Building
Coloplast £5,000
Greater Access to Effective Healthcare, Information & Support
- World MS Day
Merck £110,000
Improved Scientific Understanding
- Atlas of MS
Greater Access to Effective Healthcare, Information & Support
- Access to Diagnosis
- Improving Access to Information
- World MS Day
A Stronger Broader Global MS Movement
- Organisational Development and Movement Building
Novartis £100,000
Improved Scientific Understanding
- Atlas of MS
Greater Access to Effective Healthcare, Information & Support
- Access to Diagnosis
- Improving Access to Information
- World MS Day
A Stronger Broader Global MS Movement
- Organisational Development and Movement Building
F. Hoffmann-La Roche £110,000
Improved Scientific Understanding
- Atlas of MS
Greater Access to Effective Healthcare, Information & Support
- Access to Diagnosis
- Improving Access to Information
- World MS Day
A Stronger Broader Global MS Movement
- Organisational Development and Movement Building
Sanofi £100,000
Improved Scientific Understanding
- Atlas of MS
Greater Access to Effective Healthcare, Information & Support
- Access to Diagnosis
A Stronger Broader Global MS Movement
- Organisational Development and Movement Building
Viatris £25,000
Greater Access to Effective Healthcare, Information & Support
- World MS Day
ECTRIMS £64,000
Improved Scientific Understanding
- McDonald Fellowship Grants
*Donations are rounded to the nearest thousand.